| ranolazine ER / Generic mfg. |
| Ongoing | 3 | 110 | Europe | FLECARDIA, Ranexa, Solution for injection/infusion, Prolonged-release tablet, FLECARDIA, Ranexa | Win Medica Pharmaceuticals S.A., Win Medica Pharmaceuticals S.A. | Restoration of sinus rhythm in patients with recent AF onset Αποκατάσταση του φλεβοκομβικού ρυθμού σε ασθενείς με ΚΜ προσφάτου ενάρξεως, Restoration of sinus rhythm in patients with recent AF onset Αποκατάσταση του φλεβοκομβικού ρυθμού σε ασθενείς με ΚΜ προσφάτου ενάρξεως, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2011-000111-26: Effect of late sodium current inhibition on MRI measured diastolic dysfunction and myocardial perfusion reserve in aortic stenosis - a proof of concept study. |
|
|
| Ongoing | 2 | 20 | Europe | Ranexa, Ranexa, Ranexa | A. MENARINI PHARMA U.K., | Aortic stenosis | | | | |
2015-003149-24: Effect of Ranolazine in patients with impaired left ventricular function due to their stable angina for the presence of an abnormal ventricular contractile status that is maintained in the post-systolic Effetto della Ranolazina in pazienti con funzione ventricolare sinistra compromessa a causa della loro angina stabile per la presenza di un anomalo stato contrattile ventricolare che si mantiene nella fase post-sistolica |
|
|
| Not yet recruiting | 2 | 28 | Europe | RANEXA, Prolonged-release tablet, RANEXA - 375 MG-COMPRESSA A RILASCIO PROLUNGATO-USO ORALE-BLISTER(PVC/PVDC/ALLUMINIO) 30 COMPRESSE, RANEXA - 500 MG-COMPRESSA A RILASCIO PROLUNGATO-USO ORALE-BLISTER(PVC/PVDC/ALLUMINIO) 30 COMPRESSE, RANEXA - 750 MG-COMPRESSA A RILASCIO PROLUNGATO-USO ORALE-BLISTER(PVC/PVDC/ALLUMINIO) 30 COMPRESSE | AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, Menarini Internatinal Operations Luxemburg S.A. | Stable angina with normal ejection fraction Angina stabile con frazione di eiezione nella norma, Stable angina Angina stabile, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2015-004402-42: A pilot study assessing the effects of Ranolazine on small heart vessels dysfunction in patients with hypertrophic cardiomyopathy Studio pilota per valutare l’effetto di ranolazina sulla disfunzione microvascolare coronarica in pazienti affetti da cardiomiopatia ipertrofica |
|
|
| Ongoing | 2 | 24 | Europe | Ranolazina Ranexa, [C01EB18], Prolonged-release tablet, RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | OSPEDALE SAN RAFFAELE, Menarini International Operations Luxembourg S.A. | Hypertrophic cardiomyopathy Cardiomiopatia ipertrofica primaria, Inherited increase of the thickness of the left ventricular wall Aumento dello spessore delle pareti cardiache di origine congenita, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Not yet recruiting | 2 | 30 | NA | Empagliflozin, Jardiance, Ranolazine, Corzyna | University of Alberta, Canadian Heart Function Alliance, Accelerating Clinical Trial (ACT) Consortium, Ottawa Heart Institute Research Corporation, Team PHenomenal Hope | Pulmonary Hypertension, Right Ventricular Dysfunction, Right Heart Failure | 08/25 | 12/25 | | |
| Not yet recruiting | 2 | 72 | US | Ranolazine, Ranexa, Placebo | Jeffrey Statland, ALS Association | Amyotrophic Lateral Sclerosis | 03/25 | 12/26 | | |
| Terminated | 2 | 4 | US | Ranolazine, Placebo | Vanderbilt University Medical Center | Crohn's Disease, Inflammatory Bowel Disease | 04/24 | 04/24 | | |
